Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion type Assertion NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_head.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion description "[Currently, the inhibitor of the epidermal growth factor receptor tyrosine kinase erlotinib is widely used for the treatment of non-small cell lung cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_provenance.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion evidence source_evidence_literature NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_provenance.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion SIO_000772 20736807 NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_provenance.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion wasDerivedFrom befree-2016 NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_provenance.
- NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_assertion wasGeneratedBy ECO_0000203 NP834879.RAA_ATwu5OA-vCnMJ_sBaerGbe3w4pW66YznTxd-RZE7c130_provenance.